ABSCI CORP (ABSI) — insider trading
Health Care · NASDAQ
ABSCI CORP (ABSI) has 21 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 21 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Szela Mary T | Director | Open-market purchase | 12,900 | $11.54 | $148.9K | Form 4 |
| 2026-06-24 | McClain Sean | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 59,896 | $10.08 | $603.5K | Form 4 |
| 2026-06-04 | Szela Mary T | Director | Grant / award / vesting (derivative) | 33,200 | $0.00 | $0 | Form 4/A |
| 2026-06-04 | Szela Mary T | Director | Grant / award / vesting | 8,400 | $0.00 | $0 | Form 4/A |
| 2026-06-04 | MCGINNIS KAREN K | Director | Grant / award / vesting (derivative) | 39,800 | $0.00 | $0 | Form 4 |
| 2026-06-04 | MCGINNIS KAREN K | Director | Grant / award / vesting | 10,100 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Sirosh Joseph | Director | Grant / award / vesting (derivative) | 39,800 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Sirosh Joseph | Director | Grant / award / vesting | 10,100 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Rabinovitsj Daniel A | Director | Grant / award / vesting (derivative) | 39,800 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Rabinovitsj Daniel A | Director | Grant / award / vesting | 10,100 | $0.00 | $0 | Form 4 |
| 2026-06-04 | VAN HOUTEN FRANS | Director | Grant / award / vesting (derivative) | 39,800 | $0.00 | $0 | Form 4 |
| 2026-06-04 | VAN HOUTEN FRANS | Director | Grant / award / vesting | 10,100 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Pangalos Menelas N | Director | Grant / award / vesting (derivative) | 39,800 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Pangalos Menelas N | Director | Grant / award / vesting | 10,100 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Szela Mary T | Director | Grant / award / vesting (derivative) | 39,800 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Szela Mary T | Director | Grant / award / vesting | 10,100 | $0.00 | $0 | Form 4 |
| 2026-05-31 | Jonasson Zachariah | Officer (CFO / CBO) | Shares withheld for taxes / exercise cost | 8,319 | $6.75 | $56.2K | Form 4 |
| 2026-05-13 | Pangalos Menelas N | Director | Open-market purchase | 37,453 | $5.36 | $200.7K | Form 4 |
| 2026-03-03 | Walker Shelby J. | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 9,825 | $2.80 | $27.5K | Form 4/A |
| 2026-03-02 | Walker Shelby J. | Officer (Chief Legal Officer) | Grant / award / vesting (derivative) | 356,300 | $0.00 | $0 | Form 4/A |
| 2026-03-02 | Walker Shelby J. | Officer (Chief Legal Officer) | Grant / award / vesting | 90,300 | $0.00 | $0 | Form 4/A |
Ask the chat about ABSI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ABSCI CORP (ABSI).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.